1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Aldosterone antagonists 1.2.3 Angiotensin-converting enzyme (ACE) inhibitors 1.2.4 Angiotensin II receptor blockers (ARBs) 1.2.5 Beta-blockers 1.3 Market by Application 1.3.1 Global Dilated Cardiomyopathy Therapeutic Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Academic Institutions 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Dilated Cardiomyopathy Therapeutic Market Perspective (2016-2027) 2.2 Dilated Cardiomyopathy Therapeutic Growth Trends by Regions 2.2.1 Dilated Cardiomyopathy Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Dilated Cardiomyopathy Therapeutic Historic Market Share by Regions (2016-2021) 2.2.3 Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Regions (2022-2027) 2.3 Dilated Cardiomyopathy Therapeutic Industry Dynamic 2.3.1 Dilated Cardiomyopathy Therapeutic Market Trends 2.3.2 Dilated Cardiomyopathy Therapeutic Market Drivers 2.3.3 Dilated Cardiomyopathy Therapeutic Market Challenges 2.3.4 Dilated Cardiomyopathy Therapeutic Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Dilated Cardiomyopathy Therapeutic Players by Revenue 3.1.1 Global Top Dilated Cardiomyopathy Therapeutic Players by Revenue (2016-2021) 3.1.2 Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Players (2016-2021) 3.2 Global Dilated Cardiomyopathy Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Dilated Cardiomyopathy Therapeutic Revenue 3.4 Global Dilated Cardiomyopathy Therapeutic Market Concentration Ratio 3.4.1 Global Dilated Cardiomyopathy Therapeutic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Dilated Cardiomyopathy Therapeutic Revenue in 2020 3.5 Dilated Cardiomyopathy Therapeutic Key Players Head office and Area Served 3.6 Key Players Dilated Cardiomyopathy Therapeutic Product Solution and Service 3.7 Date of Enter into Dilated Cardiomyopathy Therapeutic Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Dilated Cardiomyopathy Therapeutic Breakdown Data by Type 4.1 Global Dilated Cardiomyopathy Therapeutic Historic Market Size by Type (2016-2021) 4.2 Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Type (2022-2027) 5 Dilated Cardiomyopathy Therapeutic Breakdown Data by Application 5.1 Global Dilated Cardiomyopathy Therapeutic Historic Market Size by Application (2016-2021) 5.2 Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Dilated Cardiomyopathy Therapeutic Market Size (2016-2027) 6.2 North America Dilated Cardiomyopathy Therapeutic Market Size by Type 6.2.1 North America Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) 6.2.2 North America Dilated Cardiomyopathy Therapeutic Market Size by Type (2022-2027) 6.2.3 North America Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2027) 6.3 North America Dilated Cardiomyopathy Therapeutic Market Size by Application 6.3.1 North America Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2021) 6.3.2 North America Dilated Cardiomyopathy Therapeutic Market Size by Application (2022-2027) 6.3.3 North America Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2027) 6.4 North America Dilated Cardiomyopathy Therapeutic Market Size by Country 6.4.1 North America Dilated Cardiomyopathy Therapeutic Market Size by Country (2016-2021) 6.4.2 North America Dilated Cardiomyopathy Therapeutic Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Dilated Cardiomyopathy Therapeutic Market Size (2016-2027) 7.2 Europe Dilated Cardiomyopathy Therapeutic Market Size by Type 7.2.1 Europe Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) 7.2.2 Europe Dilated Cardiomyopathy Therapeutic Market Size by Type (2022-2027) 7.2.3 Europe Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2027) 7.3 Europe Dilated Cardiomyopathy Therapeutic Market Size by Application 7.3.1 Europe Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2021) 7.3.2 Europe Dilated Cardiomyopathy Therapeutic Market Size by Application (2022-2027) 7.3.3 Europe Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2027) 7.4 Europe Dilated Cardiomyopathy Therapeutic Market Size by Country 7.4.1 Europe Dilated Cardiomyopathy Therapeutic Market Size by Country (2016-2021) 7.4.2 Europe Dilated Cardiomyopathy Therapeutic Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size (2016-2027) 8.2 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Type 8.2.1 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2027) 8.3 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Application 8.3.1 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2027) 8.4 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Region 8.4.1 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Dilated Cardiomyopathy Therapeutic Market Size (2016-2027) 9.2 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type 9.2.1 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) 9.2.2 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type (2022-2027) 9.2.3 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2027) 9.3 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application 9.3.1 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2021) 9.3.2 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application (2022-2027) 9.3.3 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2027) 9.4 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country 9.4.1 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country (2016-2021) 9.4.2 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size (2016-2027) 10.2 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Type 10.2.1 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2027) 10.3 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Application 10.3.1 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2027) 10.4 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Country 10.4.1 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Array BioPharma, Inc. 11.1.1 Array BioPharma, Inc. Company Details 11.1.2 Array BioPharma, Inc. Business Overview 11.1.3 Array BioPharma, Inc. Dilated Cardiomyopathy Therapeutic Introduction 11.1.4 Array BioPharma, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.1.5 Array BioPharma, Inc. Recent Development 11.2 AstraZeneca plc. 11.2.1 AstraZeneca plc. Company Details 11.2.2 AstraZeneca plc. Business Overview 11.2.3 AstraZeneca plc. Dilated Cardiomyopathy Therapeutic Introduction 11.2.4 AstraZeneca plc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.2.5 AstraZeneca plc. Recent Development 11.3 Celladon Corporation 11.3.1 Celladon Corporation Company Details 11.3.2 Celladon Corporation Business Overview 11.3.3 Celladon Corporation Dilated Cardiomyopathy Therapeutic Introduction 11.3.4 Celladon Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.3.5 Celladon Corporation Recent Development 11.4 GlaxoSmithKline plc 11.4.1 GlaxoSmithKline plc Company Details 11.4.2 GlaxoSmithKline plc Business Overview 11.4.3 GlaxoSmithKline plc Dilated Cardiomyopathy Therapeutic Introduction 11.4.4 GlaxoSmithKline plc Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.4.5 GlaxoSmithKline plc Recent Development 11.5 Janssen Pharmaceuticals, Inc. (J&J) 11.5.1 Janssen Pharmaceuticals, Inc. (J&J) Company Details 11.5.2 Janssen Pharmaceuticals, Inc. (J&J) Business Overview 11.5.3 Janssen Pharmaceuticals, Inc. (J&J) Dilated Cardiomyopathy Therapeutic Introduction 11.5.4 Janssen Pharmaceuticals, Inc. (J&J) Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.5.5 Janssen Pharmaceuticals, Inc. (J&J) Recent Development 11.6 Merck & Co., Inc. 11.6.1 Merck & Co., Inc. Company Details 11.6.2 Merck & Co., Inc. Business Overview 11.6.3 Merck & Co., Inc. Dilated Cardiomyopathy Therapeutic Introduction 11.6.4 Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.6.5 Merck & Co., Inc. Recent Development 11.7 Novartis International AG 11.7.1 Novartis International AG Company Details 11.7.2 Novartis International AG Business Overview 11.7.3 Novartis International AG Dilated Cardiomyopathy Therapeutic Introduction 11.7.4 Novartis International AG Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.7.5 Novartis International AG Recent Development 11.8 Pfizer, Inc. 11.8.1 Pfizer, Inc. Company Details 11.8.2 Pfizer, Inc. Business Overview 11.8.3 Pfizer, Inc. Dilated Cardiomyopathy Therapeutic Introduction 11.8.4 Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.8.5 Pfizer, Inc. Recent Development 11.9 Sanofi S.A. 11.9.1 Sanofi S.A. Company Details 11.9.2 Sanofi S.A. Business Overview 11.9.3 Sanofi S.A. Dilated Cardiomyopathy Therapeutic Introduction 11.9.4 Sanofi S.A. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.9.5 Sanofi S.A. Recent Development 11.10 Teva Pharmaceutical Industries Ltd. 11.10.1 Teva Pharmaceutical Industries Ltd. Company Details 11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview 11.10.3 Teva Pharmaceutical Industries Ltd. Dilated Cardiomyopathy Therapeutic Introduction 11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development 11.11 Vericel Corporation 11.11.1 Vericel Corporation Company Details 11.11.2 Vericel Corporation Business Overview 11.11.3 Vericel Corporation Dilated Cardiomyopathy Therapeutic Introduction 11.11.4 Vericel Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) 11.11.5 Vericel Corporation Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Aldosterone antagonists Table 3. Key Players of Angiotensin-converting enzyme (ACE) inhibitors Table 4. Key Players of Angiotensin II receptor blockers (ARBs) Table 5. Key Players of Beta-blockers Table 6. Global Dilated Cardiomyopathy Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Dilated Cardiomyopathy Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Dilated Cardiomyopathy Therapeutic Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Dilated Cardiomyopathy Therapeutic Market Share by Regions (2016-2021) Table 10. Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Dilated Cardiomyopathy Therapeutic Market Share by Regions (2022-2027) Table 12. Dilated Cardiomyopathy Therapeutic Market Trends Table 13. Dilated Cardiomyopathy Therapeutic Market Drivers Table 14. Dilated Cardiomyopathy Therapeutic Market Challenges Table 15. Dilated Cardiomyopathy Therapeutic Market Restraints Table 16. Global Dilated Cardiomyopathy Therapeutic Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Dilated Cardiomyopathy Therapeutic Market Share by Players (2016-2021) Table 18. Global Top Dilated Cardiomyopathy Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dilated Cardiomyopathy Therapeutic as of 2020) Table 19. Ranking of Global Top Dilated Cardiomyopathy Therapeutic Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Dilated Cardiomyopathy Therapeutic Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Dilated Cardiomyopathy Therapeutic Product Solution and Service Table 23. Date of Enter into Dilated Cardiomyopathy Therapeutic Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 26. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Type (2016-2021) Table 27. Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Dilated Cardiomyopathy Therapeutic Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Application (2016-2021) Table 31. Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 34. North America Dilated Cardiomyopathy Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 36. North America Dilated Cardiomyopathy Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Dilated Cardiomyopathy Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Dilated Cardiomyopathy Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Dilated Cardiomyopathy Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Dilated Cardiomyopathy Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Dilated Cardiomyopathy Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Dilated Cardiomyopathy Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 63. Array BioPharma, Inc. Company Details Table 64. Array BioPharma, Inc. Business Overview Table 65. Array BioPharma, Inc. Dilated Cardiomyopathy Therapeutic Product Table 66. Array BioPharma, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 67. Array BioPharma, Inc. Recent Development Table 68. AstraZeneca plc. Company Details Table 69. AstraZeneca plc. Business Overview Table 70. AstraZeneca plc. Dilated Cardiomyopathy Therapeutic Product Table 71. AstraZeneca plc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 72. AstraZeneca plc. Recent Development Table 73. Celladon Corporation Company Details Table 74. Celladon Corporation Business Overview Table 75. Celladon Corporation Dilated Cardiomyopathy Therapeutic Product Table 76. Celladon Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 77. Celladon Corporation Recent Development Table 78. GlaxoSmithKline plc Company Details Table 79. GlaxoSmithKline plc Business Overview Table 80. GlaxoSmithKline plc Dilated Cardiomyopathy Therapeutic Product Table 81. GlaxoSmithKline plc Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 82. GlaxoSmithKline plc Recent Development Table 83. Janssen Pharmaceuticals, Inc. (J&J) Company Details Table 84. Janssen Pharmaceuticals, Inc. (J&J) Business Overview Table 85. Janssen Pharmaceuticals, Inc. (J&J) Dilated Cardiomyopathy Therapeutic Product Table 86. Janssen Pharmaceuticals, Inc. (J&J) Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 87. Janssen Pharmaceuticals, Inc. (J&J) Recent Development Table 88. Merck & Co., Inc. Company Details Table 89. Merck & Co., Inc. Business Overview Table 90. Merck & Co., Inc. Dilated Cardiomyopathy Therapeutic Product Table 91. Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 92. Merck & Co., Inc. Recent Development Table 93. Novartis International AG Company Details Table 94. Novartis International AG Business Overview Table 95. Novartis International AG Dilated Cardiomyopathy Therapeutic Product Table 96. Novartis International AG Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 97. Novartis International AG Recent Development Table 98. Pfizer, Inc. Company Details Table 99. Pfizer, Inc. Business Overview Table 100. Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 101. Pfizer, Inc. Recent Development Table 102. Sanofi S.A. Company Details Table 103. Sanofi S.A. Business Overview Table 104. Sanofi S.A. Dilated Cardiomyopathy Therapeutic Product Table 105. Sanofi S.A. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 106. Sanofi S.A. Recent Development Table 107. Teva Pharmaceutical Industries Ltd. Company Details Table 108. Teva Pharmaceutical Industries Ltd. Business Overview Table 109. Teva Pharmaceutical Industries Ltd. Dilated Cardiomyopathy Therapeutic Product Table 110. Teva Pharmaceutical Industries Ltd. Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 111. Teva Pharmaceutical Industries Ltd. Recent Development Table 112. Vericel Corporation Company Details Table 113. Vericel Corporation Business Overview Table 114. Vericel Corporation Dilated Cardiomyopathy Therapeutic Product Table 115. Vericel Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business (2016-2021) & (US$ Million) Table 116. Vericel Corporation Recent Development Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global Dilated Cardiomyopathy Therapeutic Market Share by Type: 2020 VS 2027 Figure 2. Aldosterone antagonists Features Figure 3. Angiotensin-converting enzyme (ACE) inhibitors Features Figure 4. Angiotensin II receptor blockers (ARBs) Features Figure 5. Beta-blockers Features Figure 6. Global Dilated Cardiomyopathy Therapeutic Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Academic Institutions Case Studies Figure 9. Dilated Cardiomyopathy Therapeutic Report Years Considered Figure 10. Global Dilated Cardiomyopathy Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Dilated Cardiomyopathy Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Dilated Cardiomyopathy Therapeutic Market Share by Regions: 2020 VS 2027 Figure 13. Global Dilated Cardiomyopathy Therapeutic Market Share by Regions (2022-2027) Figure 14. Global Dilated Cardiomyopathy Therapeutic Market Share by Players in 2020 Figure 15. Global Top Dilated Cardiomyopathy Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dilated Cardiomyopathy Therapeutic as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Dilated Cardiomyopathy Therapeutic Revenue in 2020 Figure 17. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Type (2016-2021) Figure 18. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Type (2022-2027) Figure 19. North America Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Dilated Cardiomyopathy Therapeutic Market Share by Type (2016-2027) Figure 21. North America Dilated Cardiomyopathy Therapeutic Market Share by Application (2016-2027) Figure 22. North America Dilated Cardiomyopathy Therapeutic Market Share by Country (2016-2027) Figure 23. United States Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Dilated Cardiomyopathy Therapeutic Market Share by Type (2016-2027) Figure 27. Europe Dilated Cardiomyopathy Therapeutic Market Share by Application (2016-2027) Figure 28. Europe Dilated Cardiomyopathy Therapeutic Market Share by Country (2016-2027) Figure 29. Germany Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Share by Type (2016-2027) Figure 37. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Share by Application (2016-2027) Figure 38. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Share by Region (2016-2027) Figure 39. China Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Dilated Cardiomyopathy Therapeutic Market Share by Type (2016-2027) Figure 47. Latin America Dilated Cardiomyopathy Therapeutic Market Share by Application (2016-2027) Figure 48. Latin America Dilated Cardiomyopathy Therapeutic Market Share by Country (2016-2027) Figure 49. Mexico Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Share by Type (2016-2027) Figure 53. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Share by Application (2016-2027) Figure 54. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Share by Country (2016-2027) Figure 55. Turkey Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Array BioPharma, Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 59. AstraZeneca plc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 60. Celladon Corporation Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 61. GlaxoSmithKline plc Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 62. Janssen Pharmaceuticals, Inc. (J&J) Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 63. Merck & Co., Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 64. Novartis International AG Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 65. Pfizer, Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 66. Sanofi S.A. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 67. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 68. Vericel Corporation Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Array BioPharma, Inc. AstraZeneca plc. Celladon Corporation GlaxoSmithKline plc Janssen Pharmaceuticals, Inc. (J&J) Merck & Co., Inc. Novartis International AG Pfizer, Inc. Sanofi S.A. Teva Pharmaceutical Industries Ltd. Vericel Corporation